Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Head & Neck 3Gynecologic 2

Conditions

Head and Neck Neoplasms 2103Squamous Cell Carcinoma of Head and Neck 1654Nasopharyngeal Carcinoma 517Thyroid Neoplasms 478Carcinoma, Non-Small-Cell Lung 438Breast Neoplasms 315Mouth Neoplasms 312Neoplasms 309Melanoma 299Oropharyngeal Neoplasms 285Colorectal Neoplasms 274Lung Neoplasms 248Carcinoma, Squamous Cell 240Neoplasm Metastasis 235Ovarian Neoplasms 228Uterine Cervical Neoplasms 204Stomach Neoplasms 195Salivary Gland Neoplasms 192Laryngeal Neoplasms 192Nasopharyngeal Neoplasms 189Carcinoma, Renal Cell 183Esophageal Neoplasms 179Pancreatic Neoplasms 176Prostatic Neoplasms 158Sarcoma 142Triple Negative Breast Neoplasms 136Urinary Bladder Neoplasms 135Recurrence 128Endometrial Neoplasms 124Hypopharyngeal Neoplasms 121

Interventions

Radiotherapy, Intensity-Modulated 1Narrow Band Imaging 1Microsurgery 1Lasers, Gas 1Laser Therapy 1Cisplatin 1Celecoxib 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Papilloma × Head & Neck × Clear all
NCT05388773 2025-06-19

Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer

University of Pittsburgh

Phase 2 Recruiting
150 enrolled
Head & Neck

Carcinoma, Squamous Cell, DNA Virus Infections, Head and Neck Neoplasms, Stomatognathic Diseases, Neoplasms, Glandular and Epithelial, Oropharyngeal Neoplasms, Otorhinolaryngologic Diseases, Otorhinolaryngologic Neoplasms, Papilloma, Pharyngeal Diseases, Pharyngeal Neoplasms, Tumor Virus Infections, Papillomavirus Infections

NCT01175499 2014-08-19

TNFE-NBI

University of California, San Francisco

Phase NA Withdrawn
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Oropharyngeal Neoplasms, Papilloma

NCT00592319 2012-08-31

Celebrex (Celecoxib) Treatment of Laryngeal Papilloma

Boston University

Phase 2 Terminated
10 enrolled 6 charts
Head & Neck

Laryngeal papillomatosis, Papilloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡